全文获取类型
收费全文 | 157441篇 |
免费 | 33391篇 |
国内免费 | 2407篇 |
专业分类
耳鼻咽喉 | 5208篇 |
儿科学 | 5642篇 |
妇产科学 | 2567篇 |
基础医学 | 4226篇 |
口腔科学 | 1674篇 |
临床医学 | 27564篇 |
内科学 | 48578篇 |
皮肤病学 | 7473篇 |
神经病学 | 15458篇 |
特种医学 | 6610篇 |
外国民族医学 | 1篇 |
外科学 | 42643篇 |
综合类 | 548篇 |
现状与发展 | 72篇 |
一般理论 | 14篇 |
预防医学 | 7881篇 |
眼科学 | 3539篇 |
药学 | 1430篇 |
中国医学 | 13篇 |
肿瘤学 | 12098篇 |
出版年
2024年 | 514篇 |
2023年 | 4828篇 |
2022年 | 1222篇 |
2021年 | 3255篇 |
2020年 | 6133篇 |
2019年 | 2337篇 |
2018年 | 7583篇 |
2017年 | 7488篇 |
2016年 | 8531篇 |
2015年 | 8549篇 |
2014年 | 15702篇 |
2013年 | 15941篇 |
2012年 | 5881篇 |
2011年 | 5924篇 |
2010年 | 10605篇 |
2009年 | 14444篇 |
2008年 | 6128篇 |
2007年 | 4422篇 |
2006年 | 6832篇 |
2005年 | 4067篇 |
2004年 | 3323篇 |
2003年 | 2284篇 |
2002年 | 2373篇 |
2001年 | 4013篇 |
2000年 | 3214篇 |
1999年 | 3387篇 |
1998年 | 3741篇 |
1997年 | 3552篇 |
1996年 | 3426篇 |
1995年 | 3281篇 |
1994年 | 2017篇 |
1993年 | 1616篇 |
1992年 | 1558篇 |
1991年 | 1590篇 |
1990年 | 1220篇 |
1989年 | 1316篇 |
1988年 | 1151篇 |
1987年 | 962篇 |
1986年 | 1024篇 |
1985年 | 842篇 |
1984年 | 654篇 |
1983年 | 610篇 |
1982年 | 578篇 |
1981年 | 460篇 |
1980年 | 412篇 |
1979年 | 400篇 |
1978年 | 417篇 |
1977年 | 450篇 |
1975年 | 336篇 |
1972年 | 355篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
81.
82.
83.
84.
Status migrainosus is defined by the international classification of headache disorders (ICHD) criteria as a debilitating migraine lasting more then 72 hours. The epidemiology of status migrainosus is still unknown in adult and children, and frequently underdiagnosed. Children and adolescents often end up in the emergency room with an intractable headache that failed outpatient therapy. Six to seven percent of these children do not respond to acute infusion therapy and require hospitalization. It is imperative that more aggressive therapy is considered when patients are affected by a severe intractable headache to prevent further disability and returning the child to baseline activity. Multiple therapies are available for adults and children. Studies for acute therapy in the emergency room are available in adults and pediatric groups. Small studies are available for inpatient therapy in children and, along with available therapies for children and adolescents, are described in this review. A review of the literature shows growing evidence regarding the use of dihydroergotamine intravenously once patients are hospitalized. Effectiveness and safety have been proven in the last decades in adults and small studies in the pediatric populations. 相似文献
85.
86.
Darren R. Feldman MD Yasser Ged MBBS Chung-Han Lee PhD Andrea Knezevic MS Ana M. Molina MD Ying-Bei Chen PhD Joshua Chaim DO Devyn T. Coskey MS Samuel Murray MS Satish K. Tickoo MD Victor E. Reuter MD Sujata Patil PhD Han Xiao MD Jahan Aghalar MD Arlyn J. Apollo MD Maria I. Carlo MD Robert J. Motzer MD Martin H. Voss MD 《Cancer》2020,126(24):5247-5255
87.
James I. Geller MD Joseph G. Pressey MD Malcolm A. Smith MD Rachel A. Kudgus PhD Mariana Cajaiba MD Joel M. Reid PhD David Hall PhD Donald A. Barkauskas PhD Stephen D. Voss MD Steve Y. Cho MD Stacey L. Berg MD Jeffrey S. Dome MD PhD Elizabeth Fox MD Brenda J. Weigel MD 《Cancer》2020,126(24):5303-5310
88.
89.
90.
Cameron J. Camp 《Clinical gerontologist》2019,42(3):221-223
In far too many instances treatment of persons with dementia has reflected a fundamental denial of basic human rights. At times, these individuals are treated worse than the treatment of animals when the five basic freedoms of animals, described by Pachana in her editorial, are implemented. A number of such examples of dehumanizing (and “de-animalizing”) persons with dementia are presented. A case is made for the position that this is the direct result of the “medicalization” of dementia and “Alzheimer Disease.” This has led to the disenfranchisement of persons with dementia and their caregivers regarding the treatment of dementia, while medical “expertise” has led to a paradigm of learned helplessness while waiting for “the cure.” While the medicalization of dementia has been a financial success in terms of funding failed researcher to find a cure, it has been a catastrophe for the quality of life of persons with dementia and their caregivers. It is time to take control of the treatment of dementia back, and especially to listen to the voices of persons with dementia. It is time to take action NOW – to become disruptive to the current paradigm. The emperor and his cure have no clothes. We deserve better. We must make this change in paradigm our mission, to demand it, and to accept nothing less. Power to the people. 相似文献